Microsoft, AstraZeneca partner artificial intelligence healthcare

Microsoft, AstraZeneca partner on artificial intelligence for healthcare

11:21 AM, 4th October 2019
Microsoft, AstraZeneca join forces on artificial intelligence for healthcare
AI, machine learning, big data and automation are improving patient care pathways at every stage, from prevention through to treatment by way of diagnosis and quality of life. (File photo)

REDMOND, US: Microsoft and AstraZeneca have announced an artificial intelligence (AI) collaboration for the benefit of healthcare patients, by introducing the AI Factory for Health.

Founded in partnership with Inria, the French national research institute for the digital sciences, the AI Factory embodies Microsoft’s determination to contribute actively to the deployment and development of AI.

Since its founding, 27 startups have enjoyed the support of the AI Factory – each benefiting from a partnership encompassing technical, marketing and business elements. From mentoring to technical advice on their solutions, to recommendations on how best to promote and market them through co-marketing or co-selling, Microsoft offers each startup personalized advice at every stage of its growth.

With the benefit of two years’ maturity, Microsoft and its ecosystem have now identified five key sectors for the AI Factory to pursue: health, environment/energy, transport, financial services and food production.

The twin aims of the recently announced AI Factory for Health are to support innovation in the healthcare sector and to help early-stage startups pursue their development in AI and cloud computing to push back the frontiers of science. Designed as a powerful accelerator for startups, this program sees itself as a co-innovation laboratory, bringing together startups, the world of research and the different sector players. With the resulting synergies, AI Factory for Health projects will work in the interests of patients and the medical corps to offer a new and individualized medicine.

Startups joining the AI Factory for Health will be able to draw on AstraZeneca’s expertise in diseases and in the needs of patients and healthcare professionals, as well as its legal skills, and its access to healthcare establishments and health data across all the countries in which it operates in Europe. Microsoft will provide access to its technological skills and the services of the Azure platform, as well as personalized support, in particular via its commercial network.

Inria, the French national research institute for the digital sciences, France Digitale, the iPEPS-ICM incubator and venture capital investors Partech and Serena are also partnering with the AI Factory for Health and will be involved at the various stages of the program – AI startup sourcing, selection process, coaching, etc. – to bring their expertise to the table.

In today’s world, technology is transforming many practices in healthcare, in addition to the development of therapeutic solutions, putting patients at the heart of the system and opening the way to truly personalized medicine. AI, machine learning, big data and automation are improving patient care pathways at every stage, from prevention through to treatment by way of diagnosis and quality of life.

Thanks to more accurate and frequent monitoring of the effects of drugs, or with the help of digital companions able to answer questions not put to the medical team at the time, patients will enjoy greater peace of mind about the care they receive, both at home and in hospital. These changes involve recording incredibly large and diverse amounts of data from multiple sources, as well as working with a wide array of traditional and new partners.

“In addition to developing innovative medicines, we want to find more ways to support patients throughout their journey. Our belief is that by deepening our understanding of diseases, and of patient expectations and experiences, we can further improve their quality of life. We also firmly believe that putting patients at the heart of the healthcare system is a collective endeavor that calls for the combined knowledge and skills of many partners. That is why I am pleased that the teams from AstraZeneca and Microsoft are joining forces and laying the foundations of a partnership with the AI Factory for Health,” said Iskra Reic, EVP Europe & Canada, AstraZeneca.

“Our aim for the health sector is to contribute towards creating a digital intelligence that will bring benefits to both healthcare professionals and patients. This collaboration with AstraZeneca is rooted in a determination to find new solutions that are less burdensome and more effective for patients, throughout the care pathway,” added Elena Bonfiglioli, Regional business leader health and lifesciences EMEA.

© Worldofchemicals News 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


BP CEO Bob Dudley to step down, Upstream chief to succeed

LONDON, UK: BP Plc said that Bob Dudley (64) has decided to step down as group chief executive officer (CEO) and from the BP Board following delivery ...

Read more
Equinor to sell 25% interest in Arkona offshore wind farm

STAVANGER, NORWAY: Equinor ASA has entered into an agreement to sell a 25% ownership interest in the Arkona offshore wind farm to funds advised by Cre ...

Read more
AstraZeneca sells acid reflux drug rights to Germany's Cheplapharm

CAMBRIDGE, UK: AstraZeneca Plc said that it would sell the global commercial rights for its drug to treat acid reflux to German pharmaceutical company ...

Read more
Archroma to present latest system solutions towards sustainable colours

REINACH, SWITZERLAND: Archroma to present its latest innovations and system solutions aimed to help technical textile manufacturers in India with opti ...

Read more
Stolt-Nielsen appoints new president for tankers business

LONDON, US: Stolt-Nielsen Limited has appointed Lucas Vos as President Stolt Tankers, with effect from 11th October 2019. Vos succeeds Mark Marte ...

Read more
Maire Tecnimont signs contract for new ammonia-urea complex with EuroChem

MILAN, ITALY: Maire Tecnimont has signed a memorandum of intent (MoI) with EuroChem, a leading global fertilizer company. According to the MoI, Tecni ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X